Abstract:TO THE EDITOR—Brucellosis is a common zoonotic disease worldwide [1]. The epidemiology of human brucellosis has drastically changed owing to changing sanitary and socioeconomic conditions, and the substantial increase in international travel. New foci of human brucellosis have emerged or reemerged, with brucellosis becoming a travel-related disease, particularly in nonendemic areas [2–4]. Awareness of the geographic distribution and characteristics of brucellosis is valuable not only for the disease control in endemic areas, but also for preventing and diagnosing travel-associated disease in nonendemic areas [5, 6]. To investigate the geographic distribution of the human brucellosis epidemic in China, data were extracted from the National Notifiable Disease Surveillance System and analyzed. From December 2004 to July 2010, 141 604 laboratoryconfirmed cases were reported. A geographic distribution analysis showed that brucellosis is mainly distributed in some of the northern provinces of China. The 5 provinces with the highest incidence include Inner Mongolia (45.83%), Shanxi (13.94%), Heilongjiang (13.82%), Jilin (10.29%), and Hebei (6.31%); these provinces accounted for >90% of the reported cases. Nationwide, the annual incidence, at a county level, ranged from 0.00 to 1395.84 per 100 000 (Figure 1). Timely diagnosis is important for treating brucellosis and preventing chronic infections [7]. We examined the case data for possible contributing factors to delayed diagnoses. Of these 141 604 confirmed cases, only 26.98% were diagnosed within 7 days of symptom onset, 43.83% within 14 days, and 2.39% longer than 6 months, indicating that a large proportion of the cases had a delayed diagnosis. Further analysis showed that the average diagnosis delay was shorter in the high-incidence areas than in the low-incidence areas (35 vs 59 days, P < .001), and shorter in urban areas than in villages (32.55 vs 40.62 days, P < .001). In addition, patients who traveled or migrated across provinces had longer delays than did patients residing within an area (43.54 vs 36.82 days, P < .001). These data indicated that diagnosis delays were multifactorial and may have contributed to the chronicity of brucellosis in some population segments. Epidemiological information regarding 2060 cases were collected from brucellosis clinics and analyzed to investigate the reasons for the delays in diagnosis. Surprisingly, 57.62% of the patients had been misdiagnosed or suspected of having other diseases with similar clinical symptoms. Approximately 24.34% of the “delayed diagnosis” patients had traveled to or migrated from a high-risk area. All the patients had experienceddirect contactwith animals and/or consumed contaminated animal products prior to disease onset. The absence of characteristic symptoms and a general unawareness of epidemiological information contributed to the misdiagnoses. The lackof typical clinicalmanifestations makes it difficult to diagnose brucellosis, primarily contributing to the misdiagnosis and delay. The availability of additional information regarding the geographic

Association Between Diagnostic Delays and Spinal Involvement in Human Brucellosis: A Retrospective Case-Control Study

Imaging-Assisted Diagnosis and Characteristics of Suspected Spinal Brucellosis: A Retrospective Study of 72 Cases

Factors Associated With Diagnostic Delays in Human Brucellosis in Tongliao City, Inner Mongolia Autonomous Region, China

Clinical characteristic, management, and outcomes of cervical spinal brucellosis: a retrospective cohort study over 1-year postoperative follow-up

Brucella cultures characteristics, clinical characteristics, and infection biomarkers of human Brucellosis

Exploring the Complex Landscape of Spine Brucellosis

Real-time polymerase chain reaction detection and surgical treatment of thoracic and lumbar spondylitis due to Brucella infection: two typical case reports

Case Report: Metagenomic Next-Generation Sequencing Confirmed a Case of Spine Infection with Brucella melitensis in Non-Endemic Area

Improved Early Detection of Focal Brucellosis Complications with Anti- Brucella IgG

A proposed management classification for spinal brucellosis from India

Associated factors in distinguishing patients with brucellosis from suspected cases

Asymptomatic brucellosis infection in humans: implications for diagnosis and prevention.

One-stage posterior surgery combined with anti-Brucella therapy in the management of lumbosacral brucellosis spondylitis: a retrospective study

[One-stage posterior debridement and spinal internal fixation for the treatment of lumbar Brucellar spondylitis]

Human brucellosis mimicking axial spondyloarthritis: a challenge for rheumatologists when applying the 2009 ASAS criteria

Cervical Brucella Spondylitis: A Case Report on Diagnosis and Surgical Management

The Evaluation of the Clinical, Laboratory, and Radiological Findings of 16 Cases of Brucellar Spondylitis

Neurobrucellosis: a Clinical Analysis of 30 Cases

[Medical costs of brucellosis patients in Datong of Shanxi province, 2017-2019]

Evaluation of risk factors for the development of bacteremia and complications in patients with brucellosis: Is it possible to predict the clinical course?

Human Brucellosis, a Heterogeneously Distributed, Delayed, and Misdiagnosed Disease in China.